2011 Artemisinin Conference Agenda and Presentations

Day 1, Wednesday 2nd November 2011

Time

 

Session

 

Speakers/Facilitators

8.00-9.00

 

Registration

   

9.00-9.15

 

Opening remarks, objectives and conference format/housekeeping

 

Malcolm Cutler, Jan Van Erps, Andrea Bosman, Yohannes Ambachew

9.15-9.30

 

Welcome and official opening

 

Honorable Minister of Health, VN

9.30-10.00

 

Keynote address: Artemisinin Resistance

 

Professor Hien – Oxford University Clinical Research Vietnam Unit

       

Facilitator – Jan Van Erps

10.00-10.30

 

RBM-WHO Roundtable on ACT Supply on 8th Sept 2011

 

Prashant Yadav - RBM PSM Working Group

 

Global Fund – ACT Manufacturers Meeting on 1st Nov 2011

 

Sophia Logez - Global Fund

 

UNITAID Consultative Forum – Malaria Recommendations

 

Yohannes Ambachew - UNITAID

10.30-11.00

 

Tea/Coffee break

   
       

Facilitator – Andrea Bosman

11.00-11.30

 

Demand Forecast ACTs

 

Mathieu Lamiaux - Boston Consulting Group (BCG)

11.30-12.00

 

AMFm Implementation Report and Next Steps

 

Global Fund, AMFm

12.00-12.15

 

Artemisinin Supply, Costing and Pricing

 

Jacques Pilloy - RBM/A2S2

12.15–13.00

 

Artemisinin Production Reports

 

China – Christine Lin – PIDI Standard

   

Vietnam – Bui Minh Ut - Cat Khanh

   

Madagascar – Charles Giblain – Bionexx

   

East Africa – Patrick Henfrey, Botanical Extracts

13.00-14.00

 

Lunch

   
       

Facilitator – Malcolm Cutler

14.00-15.00

 

Panel Discussion – Observations, and Suggestions on how to ensure Accurate Planning of ACT, API and Artemisinin Needs (main points for further in-depth discussion during the Break Out Sessions)

 

Panel to Include Representatives of: Donors; Procurement Agencies; and ACT/API Manufacturers

15.00-16.00

 

New Developments in High Yielding Artemisia Varieties and Production Methods

 

High Yielding Trials Xavier Simonnet, Mediplant

   

High Yielding Varieties – Dianna Bowles, CNAP, York, UK & Bert van der Feltz, East- West Seeds

16.00-16.30

 

Tea/Coffee Break

   

16.30–17.30

 

Results of New Purification Technology on Increasing Production Efficiency and Reducing Costs

 

Silica Gel Purification – Parag Shah – Elysian Life Sciences

   

New Purification Technology to Increase Efficiency and Reduce Costs - Bhupinder Khambay, Kamtech Tech, UK

 

Research into New Derivatives & Derivitisation Technology

 

Alexei Lapkin – University of Warwick, UK

 

 

Day 2, Thursday 3rd November 2011

Time

 

Session

 

Speakers/Facilitators

       

Facilitator – Jean-Marie Kindermans

9.00-9.10

 

Key points from Day 1 for further discussion at Break Out Sessions

 

Antony Ellman, Conference Rapporteur

9.10-9.40

 

Semi-Synthetic Artemisinin Progress Report

 

Tue Nguyen and Michel Arnoux, Sanofi / One World Institute

9.40-10.10

 

Assured Artemisinin Supply System (A2S2) – Project Update and next steps including proposal for an Artemisinin/API/ACT ‘Industry’ Association

 

Jan van Duijn, i+Solutions (A2S2 lead agent)

   

Tea/Coffee Break served in Break Out Sessions

   

10.10-13.10

 

1) Break Out Session on Stabilising Artemisinin/API/ACT Supply Market demand/timing, and Artemisinin/API/ACT production planning

 

Facilitators/Rapporteurs – Andrea Bosman and Jan Van Erps

 

2) Break Out Session on Technical Issues and Developments: High Yielding Artemisia Varieties; Artemisinin Extraction, Purification; Artemisinin Analysis and Quality Requirements as Starting Material; Derivitisation

 

Facilitators/Rapporteurs – Anthony Ellman and Bhupinder Khambay

Presentations:

Trials with Symbiotic Fungus – Ajit Varma – Amity University, India

Bioengineered Artemisia annua L. variety with higher artemisinin concentration over-expressing hmgr and ads genes - Professor M. Z. Abdin - Jamia Hamdard, Hamdard Nagar, New Delhi, India

Quality requirements for artemisinin as a starting material in the production of antimalarial active pharmaceutical ingredients (APIs) - Dr Herbert Schmidt - WHO

13.10-14.30

 

Lunch

   

14.30-15.30

 

Presentations of conclusions and key findings of the Break Out Sessions and Conference

 

Break Out Facilitators/Rapporteurs:

Stabilising Artemisinin/API/ACT Supply – Jan van Erps

Technical Issues and Developments - Antony Ellman and Bhupinder Khambay

15.30-15.50

 

Tea/Coffee Break

   

15.50-17.00

 

General discussions and development of consensus on next steps

   

17.00

 

Closure

 

Malcolm Cutler, Andrea Bosman, Jan van Erps, Yohannes Ambachew